Literature DB >> 84034

[3H]Uridine uptake by target monolayers as a terminal label in an in vitro cell-mediated cytotoxicity assay.

G Smith, S Nicklin.   

Abstract

A terminal labelling method is described for measuring cell-mediated cytotoxicity based on the ability of surviving target cells to incorporate [3H]uridine into their RNA precursor pools. Parameters of the system were examined using whole and damaged embryonic mouse fibroblast monolayers. This assay is less laborious than direct cell counting and gives increased sensitivity at low target to effector cell ratios. The labelling time is short and, unlike similar techniques, it allows target cell monolayers to remain intact after completion of the radioassay and available for histological examination. This is important where heterogeneous target populations are employed since it allows assessment of differential cell killing and eliminates the need for duplicate cultures. The assay was used in conjunction with a well defined mouse popliteal lymph node assay to investigate the appearance of cytotoxic cells during a localised graft versus host response. Results showed a direct correlation between proliferative index and the development of highly specific cell-mediated cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 84034     DOI: 10.1016/0022-1759(79)90114-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Cytotoxic cell populations in normal and alloimmunized pregnant mice.

Authors:  G Smith; F Chappell
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

3.  Impairment of graft versus host reactivity in pregnant mice.

Authors:  S Nicklin; W D Billington
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

4.  Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor.

Authors:  Y Shemer-Avni; D Wallach; I Sarov
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

5.  A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro.

Authors:  J R Johnson; C H Ford; C E Newman; C S Woodhouse; G F Rowland; R G Simmonds
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.